title: Dopamine: PET Imaging and Parkinson Disease.
abstract: This article discusses the current use of PET imaging in the evaluation of dopamine function in Parkinson disease (PD). The article reviews the major radioligands targeting dopaminergic systems in patients with parkinsonian disorders. The primary objective is to show the novel clinical applications of molecular imaging in the diagnosis and assessment of motor and nonmotor symptoms in PD.
authors.affiliation: Center for Neurosciences, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.
authors.forename: Shichun
authors.initials: S
authors.lastname: Peng
authors.affiliation: Department of Neurology, University of British Columbia, 2221 Wesbrook Mall, Vancouver, British Columbia V2Z 2J9, Canada.
authors.forename: Doris J
authors.initials: DJ
authors.lastname: Doudet
authors.affiliation: Center for Neurosciences, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.
authors.forename: Vijay
authors.initials: V
authors.lastname: Dhawan
authors.affiliation: Center for Neurosciences, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA. Electronic address: yma@nshs.edu.
authors.forename: Yilong
authors.initials: Y
authors.lastname: Ma
keywords: Diagnosis; Disease progression; Dopamine; Imaging biomarkers; Neurodegenerative disorders; PET; Parkinsonism; Therapeutic intervention